Status:
UNKNOWN
Insulin Dose Calculation Software in Insulin Therapy
Lead Sponsor:
xiaolong zhao
Conditions:
Time in Range
Artificial Intelligence
Eligibility:
All Genders
18-70 years
Phase:
NA
Brief Summary
Insulin therapy is the mainstream glucose-lowering program for hospital glucose management. Intelligent insulin dose calculation software based on fingertip glucose monitoring is born in response to t...
Detailed Description
The problems related to blood glucose in non-endocrine departments are becoming more and more serious.Glucose control level is closely related to the prognosis and cost of inpatients. Insulin therapy ...
Eligibility Criteria
Inclusion
- 1\. Non-endocrine departments;
- 2\. Age 18-70;
- 3\. Currently using intensive insulin therapy with basic meals;
- 4\. Belong to type 1 or Type 2 diabetes
- 5\. Hospitalized patients 6. Regular meals
Exclusion
- 1\. Unwilling to participate or unable to cooperate.
- 2\. Myocardial infarction or cardiovascular and cerebrovascular events in the last 3 months;
- 3\. Glomerular filtration rate \< 45 ml/min / 1.73 m2;
- 4\. Other serious concomitant diseases;
- 5\. Liver function transaminase is 2 times higher than the upper limit of normal range;
- 6\. Use of oral hypoglycemic drugs other than metformin
- 7\. Asymptomatic hypoglycemia
Key Trial Info
Start Date :
October 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 30 2024
Estimated Enrollment :
182 Patients enrolled
Trial Details
Trial ID
NCT05389839
Start Date
October 1 2021
End Date
September 30 2024
Last Update
October 24 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Xiaolong Zhao
Shanghai, Shanghai Municipality, China, 200041